Nathaniel Zilkha, a principal with Kohlberg Kravis Roberts & Co., has joined the board of KKR portfolio company Jazz Pharmaceuticals Inc. (Nasdaq: JAZZ). He replaces KKR colleague Adam Clammer. www.jazzpharmaceuticals.com
Nathaniel Zilkha, a principal with Kohlberg Kravis Roberts & Co., has joined the board of KKR portfolio company Jazz Pharmaceuticals Inc. (Nasdaq: JAZZ). He replaces KKR colleague Adam Clammer. www.jazzpharmaceuticals.com
Copyright PEI Media
Not for publication, email or dissemination